用布罗达卢马布治疗的一般性囊性银病患者的自身免疫性血液溶解性贫血:一个病例报告
Toru Sugimoto1, Yuri Kinoshita1, Keigo Ito1
1Division of Dermatology, Nippon Medical School Musashi Kosugi Hospital.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
|August 27, 2025
概括
这项病例研究报告了一例罕见的热性自身免疫溶血性贫血 (AIHA) 病例,该病例发生在接受布罗达鲁马布治疗的患者身上. 需要进一步研究以了解这种潜在的药物诱导副作用.
科学领域:
- 皮肤病学
- 免疫学
- 血液学
背景情况:
- 牛皮涉及慢性皮肤炎症和过度扩散,通常与瘤死因α/ 素-23/ 素-17通路有关.
- 一般性型牛皮是一种严重的形式,需要有效的治疗策略.
研究的目的:
- 报告一个单一的一般性型牛皮病例,
- 在治疗牛皮时突出可能出现温暖的自身免疫溶血性贫血 (AIHA).
主要方法:
- 一个日本男子患有一般性型牛皮.
- 最初的治疗包括埃特雷丁酸,阿普雷米拉斯特和瑞桑基祖马布.
- 由于副作用的原因,治疗转换为布罗达卢马布,随后对不良事件进行监测.
主要成果:
- 患者的皮肤状况得到了改善.
- 在布罗达卢马布治疗4个月后,血红蛋白度显著下降.
- 诊断调查证实了热性自身免疫溶血性贫血 (AIHA).
结论:
- 这是第一个与布罗达卢马布治疗泛性松病相关的AIHA病例.
- 需要进一步调查AIHA与牛皮或布罗达卢马布诱导的AIHA之间的病因联系.
- 临床医生应考虑接受布罗达卢马布治疗的牛皮患者的AIHA风险.
相关概念视频
Autoimmune Disorders
667
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
667
Skin Diseases and Disorders
4.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264


